Post-translational modifications in stress granule and their implications in neurodegenerative diseases

被引:4
|
作者
Wang, Zhangshun [1 ]
Zhang, Chen'ang [1 ]
Fan, Chengyu [1 ]
Liu, Yanfen [1 ]
机构
[1] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2023年 / 1866卷 / 04期
基金
中国国家自然科学基金;
关键词
Liquid-liquid phase separation; Neurodegenerative disease; Post-translational modification; RNA-binding protein; Stress granule; Ubiquitination; FRONTOTEMPORAL LOBAR DEGENERATION; O-GLCNAC MODIFICATION; PHASE-SEPARATION; QUALITY-CONTROL; RIG-I; PROTEIN; FUS; TDP-43; BINDING; DOMAIN;
D O I
10.1016/j.bbagrm.2023.194989
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stress granules (SGs) arise as formations of mRNAs and proteins in response to translation initiation inhibition during stress. These dynamic compartments adopt a fluidic nature through liquid-liquid phase separation (LLPS), exhibiting a composition subject to constant change within cellular contexts. Research has unveiled an array of post-translational modifications (PTMs) occurring on SG proteins, intricately orchestrating SG dynamics. In the realm of neurodegenerative diseases, pathological mutant proteins congregate into insoluble aggregates alongside numerous SG proteins, manifesting resilience against disassembly. Specific PTMs conspicuously label these aggregates, designating them for subsequent degradation. The strategic manipulation of aberrant SGs via PTMs emerges as a promising avenue for therapeutic intervention. This review discerns recent strides in comprehending the impact of PTMs on LLPS behavior and the assembly/disassembly kinetics of SGs. By delving into the roles of PTMs in governing SG dynamics, we augment our cognizance of the molecular underpinnings of neurodegeneration. Furthermore, we offer invaluable insights into potential targets for therapeutic intervention in neurodegenerative afflictions, encompassing conditions like amyotrophic lateral sclerosis and frontotemporal dementia.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The impact of histone post-translational modifications in neurodegenerative diseases
    Cobos, Samantha N.
    Bennett, Seth A.
    Torrente, Mariana P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (08): : 1982 - 1991
  • [2] Post-translational modifications: Regulators of neurodegenerative proteinopathies
    Gupta, Rohan
    Sahu, Mehar
    Srivastava, Devesh
    Tiwari, Swati
    Ambasta, Rashmi K.
    Kumar, Pravir
    AGEING RESEARCH REVIEWS, 2021, 68
  • [3] Post-translational modifications in prion diseases
    Bizingre, Chloe
    Bianchi, Clara
    Baudry, Anne
    Alleaume-Butaux, Aurelie
    Schneider, Benoit
    Pietri, Mathea
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [4] Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
    Schaffert, Larissa-Nele
    Carter, Wayne G.
    BRAIN SCIENCES, 2020, 10 (04)
  • [5] Post-translational modifications of PML: consequences and implications
    Cheng, Xiwen
    Kao, Hung-Ying
    FRONTIERS IN ONCOLOGY, 2013, 2
  • [6] Post-translational modifications of transporters
    Czuba, Lindsay C.
    Hillgren, Kathleen M.
    Swaan, Peter W.
    PHARMACOLOGY & THERAPEUTICS, 2018, 192 : 88 - 99
  • [7] Crosstalk between protein post-translational modifications and phase separation
    Liu, Yang
    Feng, Wenjuan
    Wang, Yunshan
    Wu, Bin
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [8] Androgen receptor post-translational modifications and their implications for pathology
    Montoya-Novoa, Ines
    Gardeazabal-Torbado, Jose Luis
    Alegre-Marti, Andrea
    Fuentes-Prior, Pablo
    Estebanez-Perpina, Eva
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2024, 52 (04) : 1673 - 1694
  • [9] Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
    Singh, G.
    Chan, A. M.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (05) : 536 - 547
  • [10] Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases
    Li, Wei
    Li, Hong-Lian
    Wang, Jian-Zhi
    Liu, Rong
    Wang, Xiaochuan
    CELL AND BIOSCIENCE, 2024, 14 (01)